This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland
Menu

Christoph Kroener, Ph.D.
Senior Director CMC IVAC Portfolio at BioNTech SE
Speaker

Agenda Sessions

  • Chairperson’s Remarks: Leveraging Advances in mRNA and Genome Editing

    , 08:00
    View Session

  • Individualized Cancer Treatment Using mRNA Technology

    , 08:05
    View Session

At this event

Prev
Next
Jesper Lau, PhD
Vice President, Digital Science & Innovation
Novo Nordisk A/S

See Christoph at TIDES Europe: Oligonucleotide and Peptide Therapeutics